Aidoc has raised $150M in Series E funding to expand its clinical AI platform, according to the company. The round brings the company’s total funding to more than $500M.
Growth Equity at Goldman Sachs Alternatives led the financing, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures, NVIDIA’s venture capital arm.
Capital from the round will go toward further development of CARE, Aidoc’s clinical foundation model, and broader deployment of aiOS, its enterprise AI platform.
Earlier this year, CARE received FDA clearance for what Aidoc described as a comprehensive foundation-model-based triage system in clinical imaging.
Automated imaging draft-report creation is also part of the company’s planned expansion, as Aidoc works toward end-to-end AI workflows across CT and X-ray.
Nearly 2,000 hospitals use Aidoc’s technology, which analyzes more than 60M patient cases annually, according to the company.
The company said hospitals are moving from single-use AI tools toward enterprise platforms that can manage multiple applications under centralized operating and governance frameworks.
Aidoc has received 31 FDA clearances across use cases that include emergency department triage and detection of conditions on abdominal scans.
Company:Aidoc
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
